Compare Johnson & Johnson (JNJ) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs AT&T Inc. — how do they compare? Johnson & Johnson trades at $260.42 (market cap $626.09B), while AT&T Inc. trades at $24.32 (market cap $167.88B). The key difference: Johnson & Johnson is far larger — about 3.7× AT&T Inc.'s market cap, and AT&T Inc. pays the higher dividend (4.53%). Which is the better fit depends on your goals.
| JNJ | T | |
|---|---|---|
Market Cap | $626.09B | $167.88B |
Volume | 6,156,228 | — |
Sector | Health | Media |
52-Week High | $267.24 | $29.62 |
52-Week Low | $172.78 | $20.49 |
Enterprise Value | $654.37B | $313.20B |
Dividend Yield | 2.06% | 4.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.81, up 0.99% on the day and near its 52-week high. The stock exhibits bullish technical signals with strong moving average support, while fundamentals show robust profitability with a net income margin of 21.48% and consistent dividend growth. Recent earnings have mostly beaten expectations, and the company maintains a solid balance sheet with $24.52 billion in cash.
The outlook for JNJ remains positive, supported by analyst consensus and a price target of $284.50. Key opportunities include its defensive healthcare positioning and pipeline strength, though risks involve patent expirations and legal headwinds. The stock offers a stable investment with growth potential in a volatile market.
AT&T (T) trades at $24.08, up 1.18% with a bullish technical signal and strong fundamentals. The stock shows consistent earnings beats, with Q2 2026 EPS of $0.65 exceeding expectations. Valuation remains attractive with a P/E of 8.1 and dividend yield of 4.7%. Recent developments include fiber expansion and AI initiatives, while cash flow improved to $15.1B in 2025. Technical indicators show bullish moving averages with resistance near $24-25.
Outlook remains positive with 15% upside to consensus price target of $27.69. Investment appeal includes strong cash flow generation, dividend sustainability, and ongoing network investments. Key risks include competitive pressure from SpaceX's wireless ambitions and execution challenges in fiber deployment. Analyst consensus leans bullish with 41% buy ratings versus 10% sell recommendations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
